cover
Contact Name
eko subaktiansyah
Contact Email
eko.subaktiansyah@gmail.com
Phone
-
Journal Mail Official
support@inajog.com
Editorial Address
-
Location
Kota adm. jakarta pusat,
Dki jakarta
INDONESIA
Indonesian Journal of Obstetrics and Gynecology (Majalah Obstetri dan Ginekologi Indonesia)
ISSN : 23386401     EISSN : 23387335     DOI : -
Core Subject : Health,
The Indonesian Journal of Obstetrics and Gynecology is an official publication of the Indonesian Society of Obstetrics and Gynekology. INAJOG is published quarterly.
Arjuna Subject : -
Articles 26 Documents
Search results for , issue " Volume 6. No. 1. January 2018" : 26 Documents clear
Relationship between Knowledge, Attitude and Behavior of Postnatal Woman Toward Participation in Permanent Contraception Heriansyah, Jhon; Azhari, Azhari; Basir, Firmansyah; Theodorus, Theodorus
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (99.427 KB) | DOI: 10.32771/inajog.v6i1.756

Abstract

Objective: To investigate the association between knowledge,attitude, and behavior towards participation in permanentcontraception and describe factors that could affectparticipation of permanent contraception in women inRSMH Palembang.Methods: This case control study was conducted at the Departmentof Obstetrics and Gynecology, Dr. Mohammad Hoesin Hospital/Faculty of Medicine, Universitas Sriwijaya, Palembang, during theperiod of June 2016 to December 2016. Sample of the cases groupwas woman who agreed to use permanent contraception whilecontrol sample was women who refuse to use permanent contraception.Data were collected using a questionnaire. Statisticalanalysis was performed using SPSS.Results: There was a significant association between attitude,behavior, husband support, and disease complications withparticipation of permanent contraception. Factors that influencedparticipation of permanent contraception in woman in RSMHPalembang include husband support and behavior.Conclusion: Factors that influence the participation of women inRSMH safe contraception Palembang include support for herhusband and behavior.[Indones J Obstet Gynecol 2018; 6-1: 39-44]Keywords: family planning, participation, permanent contraception
A Comparative Study of Nomegestrol Acetate and a Combination of Ethinylestradiol and Levonorgestrel for Delaying Menstruation among Umrah Pilgrims Tindar, Mirzah; Effendi, Yusuf; Abadi, Adenan; Theodorus, Theodorus
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (93.299 KB) | DOI: 10.32771/inajog.v6i1.757

Abstract

Objective: To compare the effectiveness efficacy of nomegestrolacetate with and combination of ethinylestradiol and levonorgestrelas a regimen for delaying menstruation in Umrah pilgrims in Palembangcity.Methods: This single-blind randomized controlled trial was conductedin Hajj and Umrah Guidance Group in Palembang city duringDecember 2016 to January 2017. Population of this study was 30women who meet the inclusion and exclusion criteria. Frequencyand distribution of data was described in a table. Effectiveness andthe side effects treatment between the two groups were analyzedwith Chi Square test. Data was were analyzed using SPSS version18.0.Results: There were no differences in age, education, occupation,parity, body weight, height and contraceptive history betweentwo both groups (all p values > 0.05). Statistical analysis showedthere was no difference in spotting between nomegestrol acetate5 mg or a combination of levonorgestrel 150 mcg and 30 mcgethinylestradiol in Umrah pilgrims (p = 1.000). Other side effectssuch as (dizziness, depression, breast tenderness, heavy limbs,nauseam and vomiting) between the two groups could not beanalyzed because all subjects did not experience any other sideeffects.Conclusion: There is no difference in effectiveness betweennomegestrol acetate 5 mg or combination of levonorgestrel 150mcg and 30 mcg ethinylestradiol as a regimen for delayingmenses in Umrah pilgrims in Palembang city.[Indones J Obstet Gynecol 2018; 6-1: 45-49]Keywords: delay menstruation, ethinylestradiol, levonorgestrel,nomegestrol, side effects, spotting, umrah
Lselectin Levels in Patients with Endometriosis Fanggidae, Melkiandri; Loho, Maria F.T.; Mewengkang, Maya E.
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32771/inajog.v6i1.758

Abstract

Objective: To investigate the L-selectin profile in endometrioticpatients.Methods: This was a cross-sectional study. Subjects were patientsdiagnosed endometriosis based on clinical examination, transvaginalultrasound, MRI and CT scan at the Department of Obstetricsand Gynecology of Prof. Dr. R.D. Kandou Hospital Manado, SiloamHospital and Network Hospital starting from January 2017 to May2017. The blood samples in patients prior to surgery were taken ona vein and then separated to obtain serum. Further more, serumlevels of L-selectin were measured using enzyme-linked immunosorbentassay (ELISA). Data were analyzed with SPSS version 22.0to see significance level.Results: Of the 18 samples, based on age, endometriosis highest inthe group > 26 years ie 17 patients (94.44%), followed by the agegroup of 21-25 years in 1 patient (5:56%), and none of thepatients in the age group <20 years (0%). Based on parity, themost established on a parity group 0 for 11 patients (61.11%),followed by the 1-3 parity group of 7 patients (38.99%), and nopatients in the parity > 4 (0%). Based on the highest stage is thethird stage as many as 11 people (61.11%), followed by stage 4 of7 patients (38.99%), and none of the patients in stage 1 or stage 2(0%). From a statistical test used to stage endometriosis age, theT test, p value 0.286. From a statistical test according to the levelsof L-selectin on endometriosis stadium used, the T test, p value0.090. Results of correlation tests were used, namely statingPearson test p value of 0.921.Conclusion: L-selectin levels in women with endometriosisincreased according to clinical stage, but not significant in statisticaltests. There is no significant relationship between age withstages or levels of L-selectin in women with endometriosis.Keywords: adhesion, age, endometriosis, L-selectin, stage
Obstetric Risk Factors and Anal Incontinence among Women with Previous History of Vaginal Delivery Nurdin, Azizah; Irianta, Trika; Tahir, Mardiah; Chalid, Maisuri T.
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (94.381 KB) | DOI: 10.32771/inajog.v6i1.759

Abstract

Objective: To investigate the obstetric risk factors of the analincontinence in mothers with previous history of vaginaldelivery.Methods: The was a case-control study conducted in the Obstetricsand Gynecology Department of Dr.Wahidin Sudirohusodo Hospital,Faculty of Medicine, Universitas Hasanuddin, Makassar, during theperiod of February 2015 through January 2016. The researchinstruments were used to evaluate obstetric risk factors and theanal incontinence was the self-administered questionnaire and FecalIncontinence Severity Index. The data were analyzed statisticallyusing the Chi-square test with the significant value of p<0.05.Results: A total of 300 subjects were recruited in this study. Theresearch results indicated that the parity of  3, the assisted vaginaldelivery history (vacuum extraction), and the prolong secondstage of labor had a significant correlation with the anal incontinencewith p value=0.026, OR (95% CI) = 1.8 (1.07-3.03), p=0.018with OR (95% CI) =3.65 (1.2-10.7) and p=0.006 with OR (95% CI)= 2.9 (1.2-6.7).The history of episiotomy and the delivery of thebaby  4000 gram had no correlation with the anal incontinence.Conclusion: Parity, vacuum delivery and prolong second stage oflabor have an association with anal incontinence among womenwho has history of vaginal delivery.Keywords: anal incontinence, obstetric risk factors, vaginal delivery
Incidence of Pelvic and Paraaortic Lymph Node Metastasis in Epithelial Ovarian Cancer at a Tertiary Care Center Andrijono, Andrijono; Risfiandi, Risa
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (81.832 KB) | DOI: 10.32771/inajog.v6i1.760

Abstract

Objective: To investigate the incidence of pelvic and paraaorticlymph node metastasis in epithelial ovarian cancer.Methods: This was a cross-sectional study. Data were collectedfrom medical records, and from the cancer registry 1539 medicalrecords were obtained. From there, 863 patients were operatedand 676 were not, and only 401 medical records were foundcomplete, and 306 samples were excluded because they have beentreated with NAC and underwent surgery, patients who underwentsurgery but the results is not the epithelium, and patients whounderwent surgery, but the results were benign or borderline. And95 patients who underwent primary surgery and lymphadenectomyonly 55 patients have results in lymphadenectomy. This study usesa calculation of sample size with categorial descriptions, withprecision of 3% then obtained a minimum sample size of 261patients.Results: According to the characteristics of the study subjectsabove, the results were stage I, II, III respectively 60%, 10.9%, and29%. The metastasized of the lymph node paraaortic 9.1%, andpelvic/paraaortic 20% pelvic/paraaortic23.6%. Based on thedegree of differentiation the results were good differentiation30.9%, moderate differentiation 23.6%, and poor differentiation45.5%. We found that paraaortic lymph node metastasis weremost frequent at stadium III (43.8%). In relationship betweenlymph node metastasis with differentiation of epithelial ovariancancer, the most frequent epithelial ovarian cancer were one withpoor differentiation in pelvic/paraaortic lymph node with the sumof 69.2%. From analysis, there is significant difference betweenserous hystologic subtype with mucinosum subtype in pelviclymph node, significant difference between serous hystologicsubtype and clear cell in paraorta or pelvic lymph node andbetween the serous histology subtype and mucinous as well.Conclusion: Lymph node metastasis incident of ovarian epithelialcancer in paraaorta amounts 20%, pelvic 9.1% and pelvic orparaaortic 23.6%. Higher the stadium, the lymph node involvementswill be higher as well (pelvic and paraaortic). In stadium 1of mucinous subtype with well differentiation has minimal lymphnode involvement so we can be more selective in considering therisk and benefit of lymphadenectomy.[Indones J Obstet Gynecol 2018; 6-1: 60-63]Keywords: lymph node metastasis, ovarian cancer
The Effect of Cyclophosphamide Chemotherapy on Ovarian AntiMüllerian Hormone Levels in Breast Cancer Patients Liga, Elisabeth G.K.; Abdullah, Nusratuddin; Tiro, Eddy; T. Chalid, St. Maisuri
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 1. January 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (86.105 KB) | DOI: 10.32771/inajog.v6i1.761

Abstract

Objective: To evaluate cyclophosphamide effects on Anti-Müllerian hormone (AMH) levels in breast cancer patientstreated with cyclophosphamide chemotherapy.Methods: This cohort prospective study was conducted inDr. Wahidin Sudirohusodo Hospital in the Department of Obstetricsand Gynecology in collaboration with Department of Surgery,Faculty of Medicice, Universitas Hasanuddin between September2015 and June 2016. Serum levels of AMH from forty breast cancerpatients received three series of cyclophosphamide chemotherapydetermined by Enzyme Linked Immuno Sorbent Assay (ELISA).Results: Serum AMH levels decreased significant in the first series(from 2.092.04 g/ml to o.651.06 g/ml; p<0.05) through thethird series (from 1.531.34 g/ml to 0.50.65 g/ml; p<0.05) ofcyclophosphamide chemotherapy.Conclusion: AMH levels decreased significant after cyclophosphamideindicated that cyclosphosphamide decrease ovarianreserve.[Indones J Obstet Gynecol 2018; 6-1: 64-67]Keywords: anti-müllerian hormone, breast cancer, cyclophosphamide,ovarian reserveObjective: To evaluate cyclophosphamide effects on Anti-Müllerian hormone (AMH) levels in breast cancer patientstreated with cyclophosphamide chemotherapy.Methods: This cohort prospective study was conducted inDr. Wahidin Sudirohusodo Hospital in the Department of Obstetricsand Gynecology in collaboration with Department of Surgery,Faculty of Medicice, Universitas Hasanuddin between September2015 and June 2016. Serum levels of AMH from forty breast cancerpatients received three series of cyclophosphamide chemotherapydetermined by Enzyme Linked Immuno Sorbent Assay (ELISA).Results: Serum AMH levels decreased significant in the first series(from 2.092.04 g/ml to o.651.06 g/ml; p<0.05) through thethird series (from 1.531.34 g/ml to 0.50.65 g/ml; p<0.05) ofcyclophosphamide chemotherapy.Conclusion: AMH levels decreased significant after cyclophosphamideindicated that cyclosphosphamide decrease ovarianreserve.Keywords: anti-müllerian hormone, breast cancer, cyclophosphamide,ovarian reserve

Page 3 of 3 | Total Record : 26


Filter by Year

2018 2018


Filter By Issues
All Issue Volume 14. No. 1 January 2026 Volume 13. No. 4 October2025 Volume 13. No. 3 July 2025 Volume 13. No. 2 April 2025 Volume 13. No. 1 January 2025 Volume 12 No. 4 October 2024 Volume 12 No. 3 Jully 2024 Volume 12 No. 2 April 2024 Volume 12 No. 1 January 2024 Volume 11 No. 4 October 2023 Volume 11 No. 3 July 2023 Volume 11 No. 2 April 2023 Volume 11 No. 1 January 2023 Volume 10 No. 4 Oktober 2022 Volume 10 No. 3 July 2022 Volume 10 No. 2 April 2022 Volume 10 No. 1 January 2022 Volume 9 No. 4 October 2021 Volume 9 No. 3 July 2021 Volume 9 No. 2 April 2021 Volume 9 No. 1 January 2021 Volume 8 No. 4 October 2020 Volume 8 No. 3 July 2020 Volume 8 No. 2 April 2020 Volume 8 No. 1 January 2020 Volume 7 No. 4 October 2019 Volume 7 No. 3 July 2019 Volume 7 No. 2 April 2019 Volume 7 No. 2 April 2019 Volume 7, No. 1 January 2019 Volume 7, No. 1 January 2019 Volume 6 No. 4 October 2018 Volume 6 No. 4 October 2018 Volume 6 No. 3 July 2018 Volume 6 No. 3 July 2018 Volume 6. No. 2 April 2018 Volume 6. No. 2 April 2018 Volume 6. No. 1. January 2018 Volume 6. No. 1. January 2018 Volume. 5, No. 4, October 2017 Volume. 5, No. 4, October 2017 Volume. 5, No. 3, July 2017 Volume. 5, No. 3, July 2017 Volume. 5, No. 2, April 2017 Volume. 5, No. 2, April 2017 Volume. 5, No. 1, January 2017 Volume. 5, No. 1, January 2017 Volume 4, No. 4, October 2016 Volume 4, No. 4, October 2016 Volume. 4, No.3, July 2016 Volume. 4, No.3, July 2016 Volume. 4, No. 2, April 2016 Volume. 4, No. 2, April 2016 Volume. 4, No. 1, January 2016 Volume. 4, No. 1, January 2016 Volume. 3, No. 4, October 2015 Volume. 3, No. 4, October 2015 Volume. 3, No. 3, July 2015 Volume. 3, No. 3, July 2015 Volume. 3, no. 2, April 2015 Volume. 3, no. 2, April 2015 Volume. 3, No. 1, January 2015 Volume. 3, No. 1, January 2015 Volume. 2, No. 4, October 2014 Volume. 2, No. 4, October 2014 Volume. 2, No. 3, July 2014 Volume. 2, No. 3, July 2014 Volume. 2, No. 2, April 2014 Volume. 2, No. 2, April 2014 Volume. 2, No. 1, January 2014 Volume. 2, No. 1, January 2014 Volume. 37, No. 2, April 2013 Volume. 37, No. 2, April 2013 Volume 37, No. 1, January 2013 Volume 37, No. 1, January 2013 Volume. 37, No. 1, January 2013 Volume. 1, No. 4, October 2013 Volume. 1, No. 4, October 2013 Volume. 1, No. 3, July 2013 Volume. 1, No. 3, July 2013 Volume. 36, No. 4, October 2012 Volume. 36, No. 4, October 2012 Volume. 36, No. 3, July 2012 Volume. 36, No. 3, July 2012 Volume. 36, No. 2, April 2012 Volume. 36, No. 2, April 2012 Volume. 36, No. 1, January 2012 Volume. 36, No. 1, January 2012 Volume. 35, No. 4, October 2011 Volume. 35, No. 4, October 2011 Volume. 35, No. 3, July 2011 Volume. 35, No. 3, July 2011 Volume. 35, No. 2, April 2011 Volume. 35, No. 2, April 2011 Volume. 35, No. 1, January 2011 Volume. 35, No. 1, January 2011 Volume. 34, No. 4, October 2010 Volume. 34, No. 4, October 2010 Volume. 34, No. 3, July 2010 Volume. 34, No. 3, July 2010 Volume. 34. No. 2, April 2010 Volume. 34. No. 2, April 2010 Volume. 34, No. 1, January 2010 Volume. 34, No. 1, January 2010 Volume. 33. No. 4, October 2009 Volume. 33. No. 4, October 2009 Volume. 33, No. 3, July 2009 Volume. 33, No. 3, July 2009 Volume. 33, No. 2, April 2009 Volume. 33, No. 2, April 2009 Volume. 33, No. 1, January 2009 Volume. 33, No. 1, January 2009 Volume. 32, No. 4, October 2008 Volume. 32, No. 4, October 2008 Volume. 32, No. 3, July 2008 Volume. 32, No. 3, July 2008 Volume. 32, No. 2, April 2008 Volume. 32, No. 2, April 2008 Volume. 32, No. 1, January 2008 Volume. 32, No. 1, January 2008 Volume. 31, No. 4, October 2007 Volume. 31, No. 4, October 2007 Volume. 31, No. 3, July 2007 Volume. 31, No. 3, July 2007 Volume. 31, No. 2, April 2007 Volume. 31, No. 2, April 2007 Volume. 31, No. 1, January 2007 Volume. 31, No. 1, January 2007 Volume. 30, No. 4, October 2006 Volume. 30, No. 4, October 2006 Volume. 30, No. 3, July 2006 Volume. 30, No. 3, July 2006 Volume. 30, No. 2, April 2006 Volume. 30, No. 2, April 2006 Volume. 30, No. 1, January 2006 Volume. 30, No. 1, January 2006 More Issue